Purine derivatives in the study of allergic inflammation in respiratory diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 34, 1997, Pages 48-54

  Crimi, Nunzio ^a   Polosa, Riccardo ^a   Mistretta, Antonino ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Adenosine; Airway responsiveness; Asthma; Rhinitis

Indexed keywords

ADENOSINE; HISTAMINE; PROSTAGLANDIN D2; TRYPTASE;

ALLERGIC RHINITIS; ASTHMA; BRONCHOSPASM; HUMAN; MAST CELL; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW;

ADENOSINE; ANIMALS; ASTHMA; BRONCHI; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; GUINEA PIGS; HUMANS; INFLAMMATION; PURINE NUCLEOSIDES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0030981572     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04811.x     Document Type: Article

References (70)

1. Polosa R, Church MK, Holgate ST. The autacoid functions of adenosine in asthma. In: Agrewal DK and Townley RG (eds). Airway smooth muscle: modulation of receptors and response. CRC Press, Boca Raton (Florida), USA 1990;133-45.
2. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993;148:91-7.
3. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983;15: 161-5.
4. Crimi N, Polosa R, Mistretta A. Mechanisms of the effector function of adenosine in asthma and rhinitis. Drug Dev Res 1993;28:322-7.
5. Wolff J, Londos C, Cooper DMR. Adenosine receptors and the regulation of adenylate cyclase. Adv Cyclic Nucleotide Res 1981;14:199-214.
6. Daly JW. Adenosine receptors: targets for drugs. J Med Chem 1982;5:197-207.
7. Coleman RA. Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol 1976;57:51-7.
8. Fredholm BB, Brodin K, Strandberg K. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol 1979;45:336-44.
9. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effect of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appi Physiol 1986; 61:1667-76.
10. Arch JRS, Newsholm EA. The control of the metabolism and the hormonal role of adenosine. Essays Biochem 1978;14:82-123.
11. Fredholm BB. Are methylxanthines' effects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1980;1:129-32.
12. Cushley MJ, Tattersfield AE, Holgate ST. Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am Rev Respir Dis 1984;129:380-4.
13. Mann JS, Holgate ST. Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline. Br J Clin Pharmacol 1985;19:685-92.
14. Clarke H, Cushley MJ, Persson CG, Holgate ST. The protective effects of intravenous theophylline and enprofyl-line against histamine- and adenosine 5′-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol 1989;2:147-54.
15. Srikiatkhachorn A, White D, Strunk RC. Bronchial hyperreactivity to adenosine increases when theophylline is discontinued. J Allergy Clin Immunol 1991;87:312.
16. Cushley MJ, Tallant N, Holgate ST. The effect of single dose intravenous dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. Eur J Respir Dis 1986;86:185-92.
17. Crimi N, Palermo F, Oliven R, Maccarrone C, Palermo B, Vancheri C et al. Enhancing effect of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients. Allergy 1988;43:179-83.
18. 2-purinoceptor mediated mechanism. Biochem Pharmacol 1984;33:3847-52.
19. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988; 138;1143-51.
20. Phillips GD, Rafferty P, Beasley CRW, Holgate ST. The effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophos-phate in non-atopic asthma. Thorax 1987;42:939-45.
21. Rafferty P, Beasley CRW, Holgate ST. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′-monophosphate in atopic asthma. Am Rev Respir Dis 1987;136:369-73.
22. Crimi N, Palermo F, Polosa R, Oliveri R, Maccarrone C, Palermo B, et al. Effect of indomethacin on adenosine-induced bronchoconstriction. J Allergy Clin Immunol 1989; 83:921-5.
23. Phillips GD, Holgate ST. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in non-atopic asthma. Am Rev Respir Dis 1989;139:463-9.
24. Crimi N, Polosa R, Magri S, Prosperini G, Milazzo LV, Santonocito G, et al. Inhaled lysine-acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to AMP in asthmatic subjects. Eur Respir J 1995;8:905-12.
25. Church MK, Polosa R, Rimmer SJ. Cromolyn sodium and nedocromil sodium; mast cell stabilizers, neuromodulators or anti-inflammatory drugs? In: Barnes PJ, Persson CGA, Kaliner M.A. (eds). Asthma: its pathology and treatment. Marcel Dekker, New York 1991;561-93.
26. Altounyan REC, Lee TB, Rocchiccioli KMS, Shaw CL. A comparison of the inhibitory effects of nedocromil sodium and sodium cromoglycate on adenosine monophosphate-induced bronchoconstriction in atopic subjects. Eur J Respir Dis 1986;69 (Suppl. 147): 277-9.
27. Crimi N, Palermo F, Oliveri R, Vancheri C, Polosa R, Palermo B, et al. Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects. Clin. Allergy 1988;18:367-74.
28. Phillips GD, Scott VL, Richards R, Holgate ST. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 1989;2:210-17.
29. Joad JP. Characterization of the human peripheral lung adenosine receptor. Am J Respir Cell Mol Biol 1990;2: 193-8.
30. Phillips GD, Ng WH, Church MK, Holgate ST. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5′-monophosphate and allergen in atopic non asthmatic subjects. Am Rev Respir Dis 1990;141:9-13.
31. Driver AG, Kukoly C, Metzger WJ, Mustafa SJ. Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma. Am Rev Respir Dis 1991;143:1002-7.
32. Nanishima M, Akisawa T, Tanaka K, Nakagami K, Suzuki H, Noguchi E. Studies of adenosine inhalation in asthmatic patients. Arerugi 1990;39:322-9.
33. Polosa R, Ng Wh, Crimi N, Vancheri C, Holgate ST, Church MK, et al. Release of mast cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995;151:624-9.
34. Polosa R, Crimi N, Raccuglia D, Pagano C, Walters C, Church MK, et al. Histamine changes to nasal provocation with AMP and GMP in rhinitic and normal subjects. J Allergy Clin Immunol 1994;93 (1): 329.
35. Gustafsson LF, Wiklund NP, Cederqvist B. Apparent enhancement of cholinergic transmission in rabbit bronchi via adenosine A2-receptor. Eur J Pharmacol 1986;120:179-85.
36. Pauwels RA, Van der Straeten ME. An animal model for adenosine-induced bronchoconstriction. Am Rev Respir Dis 1987;136:374-8.
37. Mann JS, Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis 1985;132:1-6.
38. Polosa R, Phillips GD, Rajakulasingam K, Holgate ST. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by AMP and histamine in asthma. J Allergy Clin Immunol 1991;87:939-47.
39. Crimi N, Palermo F, Oliveri R, Polosa R, Settinieri I, Mistretta A. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine. Eur Respir J 1992;5:560-5.
40. Polosa R, Lau LCK, Holgate ST. Inhibition of adenosine 5′-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J 1990;3:665-72.
41. Polosa R, Rajakulasingam K, Prosperini G, Church MK, Holgate ST. Relative potencies and time-course of changes in adenosine 5′-monophosphate (AMP) airway responsiveness with inhaled frusemide and bumetanide in asthma. J Allergy Clin Immunol 1993;92:288-97.
42. Manzini S, Ballati L. 2-chloroadenosine induction of vagally-mediated and atropine-résistant bronchomotor responses in anaesthetised guinea pigs. Br J Pharmacol 1990;100:251-6.
43. Polosa R, Rajakulasingam K, Church MK, Holgate ST. Repeated inhalation of bradykinin attenuates adenosine 5′-monophosphate (AMP) induced bronchoconstriction in asthmatic airways. Eur Respir J 1992;5:700-6.
44. Ali S, Mustafa SJ, Driver AG, Metzger WJ. Release of adenosine in bronchoalveolar lavage fluid following allergen bronchial provocation in allergic rabbits. Am Rev Respir Dis 1991;143: A417.
45. Marquardt DL, Gruber HW, Wasserman ST. Adenosine released from stimulated mast cells. Proc Natl Acad Sci USA 1984;81:6192-6.
46. Montefort S, Gratziou C, Goulding D, Haskard DO, Howarth PH, Holgate ST, et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994;93:1411-21.
47. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, et al. 5′-AMP is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993;91:2320-5.
48. Laitinen LA, Heino M, Laitenen A, Kava T, Hauhtela T. Damage to the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985 ;131:599-606.
49. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
50. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986;233:309-19.
51. Watt AH, Penny WJ, Singh H, Routledge PA, Henderson AH. Adenosine causes transient dilation of coronary arteries in man. Br J Clin Pharmacol 1987;24:665-8.
52. Rose FR, Hirshhorn R, Weissman G, Cronstein BN. Adenosine promotes neutrophil chemotaxis. J Exp Med 1988;167:1186-94.
53. 2-receptor mediated mechanism. Br J Pharmacol 1983;80:719-26.
54. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
55. Bradding P, Feather IH, Howarth PH, et al. Interleukin-4 is localised to and released by human mast cells. J Exp Med 1992;176:1381-6.
56. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Holgate. Interleukins-4,-5, and -6 and TNFa in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
57. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway responsiveness. Chest 1994;105:687-96.
58. Moller A, Lippert U, Lessmann D, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
59. Polosa R. Renaissance of the effector role of the mast cell in bronchial asthma. Ann Ital Med Int 1995;10:126-33.
60. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, et al. Mucosal inflammation in asthma. State of the art. Am Rev Respir Dis 1990; 142:434-57.
61. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980;121: 389-413.
62. Hargreave FE, Ryan G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-55.
63. Bjorck T, Gustafsson LE, Dahlen SE. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 1992;145:1087-91.
64. Phillips GD, Holgate ST. Absence of a late response or increase in histamine responsiveness following bronchial provocation with AMP in atopic and non-atopic asthma. Clin Sci 1988;75:429-35.
65. Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984;129:1000-5.
66. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Resp Dis 1988;137:62-9.
67. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197-1203.
68. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, et al. Evidence of ongoing mast cell and eosinophil degranula-tion in symptomatic asthma airway. J Allergy Clin Immunol 1991;88:637-48.
69. Oosterhoff Y, de Jong JW, Jansen MAM, Koeter GH, Postma DS. Airway responsiveness to AMP in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993;147:553-8.
70. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine, and exercise challenges in children with asthma or pediatric chronic obstructive pulmonary disease. Thorax 1995;50:511-16.